Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Visiongain Report Claims There is Huge Potential Within the $117bn Cancer Immunotherapy Market | ||
| By: PR Newswire Association LLC. - 12 Feb 2019 | Back to overview list |
|
LONDON, February 12, 2019 /PRNewswire/ -- Global Cancer Immunotherapy Market Forecast 2019-2029 Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Hospitals, Cancer Research Centres, Clinics (Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg ) The world cancer immunotherapy market is expected to grow at a CAGR of 11.4% in the second half of the forecast period. The market reached $63bn in 2018, dominated by the monoclonal antibody segment which held 66% share of the market. How this report will benefit you In this brand new 194-page report you will receive 110 tables and 93 figures- all unavailable elsewhere. The 194-page report provides clear detailed insight into the global cancer-treating drugs market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act. Report Scope • Global cancer immunotherapy market forecasts from 2019-2029 • This report also breaks down the revenue forecast for the global cancer immunotherapy market by Technology: Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW. • This report also breaks down the revenue forecast for the global cancer immunotherapy market by Application: Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW. • This report also breaks down the revenue forecast for the world cancer immunotherapy market by End-User: Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW. • This report provides individual revenue forecasts to 2029 for these regional and national markets: Each regional market is further broken down by technology, application and end-user. • This report discusses trends in the industry and assesses drivers and restraints, as well as opportunities and threats. It also includes porters' five force analysis; threat of new entrants, power of suppliers, power of buyers, rivalry among competitors and threat of substituents. • Our study discusses the selected leading companies that are the major players in the cancer immunotherapy market: The report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments. Visiongain's study is intended for anyone requiring commercial analyses for the global cancer Immunotherapy market. You find data, trends and predictions. Buy our report today Global Cancer Immunotherapy Market Forecast 2019-2029: Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Hospitals, Cancer Research Centers, Clinics. To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-cancer-immunotherapy-market-forecast-2019-2029/ Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have. Abbott Laboratories To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com SOURCE Visiongain 
|
||
|
|
||
 | Back to overview list | |
